EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 00:15 ET (22-Jun-2026 04:15 GMT/UTC)

Unexpected findings on lung cancer CT scans may point to other non-lung cancers, study finds

Brown University
Peer-Reviewed Publication

When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs. A new study led by reserachers at the Brown University School of Public Health shows that some of those abnormalities could be signs of other undiagnosed cancers.

Journal: JAMA Network Open
Funder: National Cancer Institute

The SCD1 inhibitor aramchol, regorafenib, and metformin combine to kill uveal melanoma cells

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – March 31, 2026 – A new research paper was published in Volume 17 of Oncotarget on March 27, 2026, titled “The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells.”

Journal: Oncotarget

Targeting tumor supporting cells: Advancing CAR T success in pancreatic cancer

University of Pennsylvania
Peer-Reviewed Publication

In solid tumors such as pancreatic cancer, CAR T cell therapy is hindered by a dense barrier of connective tissue and cells that suppress the immune response. Immunologist Ellen Puré of the School of Veterinary Medicine at the University of Pennsylvania and collaborators have “melted away” this barrier using lipid nanoparticles to generate CAR T cells directed at specific cells in the barrier. This approach paves the way for a potentially safer, more accessible, and cost-effective method for using CAR T cell therapy to treat solid tumors.

Journal: Cancer Immunology Research
Funder: Alliance for Cancer Gene Therapy, Capstan Therapeutics

San Antonio Breast Cancer Symposium® fuels $39.6 million impact and advances in cancer care

The University of Texas at San Antonio Health Science Center
Business Announcement

The San Antonio Breast Cancer Symposium® drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio.

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

Hiroshima University
Peer-Reviewed Publication

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in comprehensive genomic profiling (CGP) of cancers. This framework could improve the accuracy of precision oncology by more reliable prioritization of VUS.

Journal: European Journal of Human Genetics
Funder: Hiroshima University, Ryokufukai Encouragement Award for Education and Research

Integration of single-cell multiomics data allows a more precise identification of rare cell types and states

Josep Carreras Leukaemia Research Institute
Peer-Reviewed Publication

Researchers at the Josep Carreras Leukaemia Research Institute have demonstrated that combining data from different origins enables a more precise characterisation of cell type’s diversity into tissues and organs. The team also introduced scOMM, a new machine learning tool for classifying and compare cell types across the distinct data modalities. The tool is openly available to researchers worldwide and has been successfully tested in kidney tissue, one of the most cellularly diverse organs in the human body and validated in blood and heart tissue. As the results demonstrate, when it comes to understanding complex tissues, the whole is greater than the sum of its parts.

Journal: Genome Biology

Decoding the chemical messengers: Gut microbes talk to the whole body through metabolites

Immunity & Inflammation
Peer-Reviewed Publication

Microbial metabolites influence health far beyond the intestinal tract. Yet, a systematic understanding of how these molecules precisely control specific immune cell functions and regulate disease has remained elusive. A comprehensive review by the team of Professor Changtao Jiang and Dr. Kai Wang at Peking University addresses this gap. The article provides a critical theoretical foundation for understanding the gut microbiota-metabolite-immune axis in disease pathogenesis and for developing targeted intervention strategies.

Most detailed map to date of breast tissue changes reveals role of menopause in cancer susceptibility

University of Cambridge
Peer-Reviewed Publication

Scientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause. The map reveals how, as women age, the number of cells in their breast tissue decreases, and these in turn proliferate less, and the structure of breast tissue changes. This creates a ‘micro-environment’ in which cancer cells can thrive.

Journal: Nature Aging
Funder: Cancer Research UK

PSMA therapy delays hormone therapy in prostate cancer

Radboud University Medical Center
Peer-Reviewed Publication

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all other treatment options, a new study now demonstrates that the therapy is also effective in an earlier stage of the disease. As a result, more burdensome hormone therapy can be postponed by twenty additional months, shows research led by Radboudumc.

Journal: The Lancet Oncology

Ochsner hosts no-cost Iberville Parish health fair to promote cancer awareness and prevention

Ochsner Health System
Business Announcement

The event connected community members with local providers for health screenings, education and prevention resources.

97
98
99
100
101